Semantic Scholar Open Access 2021 10 sitasi

Biologics and Novel Therapies for Food Allergy.

Sultan Albuhairi R. Rachid

Abstrak

Food allergy is a significant public health burden affecting around 10% of adults and 8% of children. Although the first peanut oral immunotherapy product received Food and Drug Administration approval in 2020, there is still an unmet need for more effective therapeutic options that minimize the risk of anaphylaxis, nutritional deficiencies, and patient's quality of life. Biologics are promising modalities, as they may improve compliance, target multiple food allergies, and treat other concomitant atopic diseases. Although omalizumab has been evaluated extensively, most biologics are more novel and have broader immunologic impact. Careful evaluation of their safety profile should therefore be conducted.

Topik & Kata Kunci

Medicine

Penulis (2)

Sultan Albuhairi

R. Rachid

Format Sitasi

APA MLA BibTeX

Albuhairi, S., Rachid, R. (2021). Biologics and Novel Therapies for Food Allergy.. https://doi.org/10.1016/j.iac.2021.01.002

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →

Lihat di Sumber doi.org/10.1016/j.iac.2021.01.002

Informasi Jurnal

Tahun Terbit: 2021
Bahasa: en
Total Sitasi: 10×
Sumber Database: Semantic Scholar
DOI: 10.1016/j.iac.2021.01.002
Akses: Open Access ✓